Adefovir plus lamivudine are more effective than adefovir alone in lamivudine‐resistant HBeAg<sup>‐</sup> chronic hepatitis B patients: A 4‐year study - Concepedia

Concepedia

Publication | Closed Access

Adefovir plus lamivudine are more effective than adefovir alone in lamivudine‐resistant HBeAg<sup>‐</sup> chronic hepatitis B patients: A 4‐year study

38

Citations

27

References

2009

Year

Themistoklis Vassiliadis, Georgios Koumerkeridis, Haralabos Koumaras, Kalliopi Patsiaoura, Nikolaos Grammatikos, Alexandros Mpoumponaris, Dimitrios Gkisakis, Konstantinos Theodoropoulos, Athanasia Panderi, Panagiotis Katsinelos,

Journal of Gastroenterology and Hepatology

Abstract

Adding ADV to LAM is more effective than switching to ADV monotherapy in LAM-resistant patients with HBeAg(-) CHB.

References

	Year	Citations

Page 1